Skip to content

Evaluation of Stenfilcon A Versus Etafilcon A

Evaluation of Stenfilcon A Versus Etafilcon A

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01809834
Enrollment
46
Registered
2013-03-13
Start date
2012-11-30
Completion date
2013-11-30
Last updated
2020-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

Evaluation of two contact lenses

Detailed description

One week dispensing, investigator-masked, randomized, contralateral study comparing the test lens against the control lens. Each subject will be randomized to wear the test lens in one eye and the control lens in the other eye simultaneously.

Interventions

DEVICEEtafilcon A

Sponsors

CooperVision, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
17 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Is at least 17 years of age and has full legal capacity to volunteer; * Has read and signed an information consent letter; * Is willing and able to follow instructions and maintain the appointment schedule; * Is correctable to a visual acuity of 20/30 or better (in each eye) with their habitual correction and the assigned study lenses; * Has astigmatism less than or equal to -1.00D; * Is an adapted soft contact lens wearer; * Demonstrates an acceptable fit with the study lenses; * Has no active anterior segment disease or known ocular disease.

Exclusion criteria

* A person will be excluded from the study if he/she: * Has never worn contact lenses before; * Has any systemic disease affecting ocular health; * Is using any systemic or topical medications that will affect ocular health; * Has any ocular pathology or severe insufficiency of lacrimal secretion (moderate to severe dry eyes) that would affect the wearing of contact lenses; * Has persistent, clinically significant corneal or conjunctival staining using sodium fluorescein dye; * Has any clinically significant lid or conjunctival abnormalities, neovascularization, corneal scars or corneal opacities; * Is aphakic; * Has undergone corneal refractive surgery; * Is participating in any other type of clinical or research study; * Has known sensitivity to the diagnostic pharmaceuticals to be used in the study.

Design outcomes

Primary

MeasureTime frameDescription
Participant's Subjective Rating of Overall Preference (Questionnaire)12-hours, 1-weekParticipants rated their overall lens preference by questionnaire. (annotated scale, 0-100, scale normalized to 0=no preference, +50=strongly prefers test lens, -50=strongly prefers control lens). Change over time measured at 12-hours, 1-week
Participant's Subjective Rating of Comfort (Questionnaire)Insertion, After Lens settling, 12-hours, 1-weekParticipants rated their comfort of lenses by subjective questionnaire (un-annotated scale, 0-100, 0=Poor comfort/intolerable, 100=Excellent comfort/cannot be felt) Change over time measured at insertion, After settling, 12-hours, 1-week
Participant's Subjective Rating of Dryness (Questionnaire)12-hours, 1-weekParticipants rated dryness of the lenses by subjective questionnaire (annotated scale, 0-100, 0=cannot be worn / extremely dry, 100=no dryness experienced at any time) Change over time measured at 12-hours, 1-week
Participant's Subjective Rating of Lens Handling for Insertion (Questionnaire)DispenseParticipants rated their lens handling experience for lens insertion by questionnaire (un-annotated scale, 0-100, 0=could not place lens on eye, 100=always easy to place lens on eye) Measured at Dispensing
Participant's Subjective Rating of Lens Handling for Removal (Questionnaire)12-hours, 1-weekParticipants rated their lens handling experience for the lens removal by questionnaire (un-annotated scale, 0-100, 0=could not remove lens from eye, 100=always easy to remove lens from eye) Change over time measured at 12-hours, 1-week
Participant's Subjective Rating of Visual Quality (Questionnaire)12-hours, 1-weekParticipants rated visual quality of the lenses by questionnaire (annotated scale, 0-100, 0=extremely poor vision all of the time. Cannot function, 100=excellent vision all of the time) Change over time measured at 12-hours, 1-week

Secondary

MeasureTime frameDescription
Investigator's Objective Assessment of Lens Surface Wettability (Biomicroscopy)Insertion, 12 hours, 1 weekInvestigators assigned a lens surface wettability grade by biomicroscopy assessment (grading scale, 0 to 4, 0=excellent, 4=severely reduced). Change over time measured after lens settling (insertion), after 12-hours wear on the dispense day (12-hours), after a minimum on one hour of lens wear at 1 week (1-week).
Investigator's Objective Assessment of Overall Fit Acceptance (Biomicroscopy)Insertion, 12 hours, 1 weekInvestigators assigned an overall fit acceptance grade by biomicroscopy assessment (grading scale, 0-4, 0=very poor, 4=very good). Change over time measured at insertion, 12-hours, 1-week
Investigator's Objective Assessment of Visual Acuity, High Contrast at High Illumination (Snellen)InsertionInvestigators tested participants using snellen charts distant to the participant in each eye (monocular) at normal lighting conditions (high illumination). (logMAR, 0.00 = 20/20 Snellen acuity, positive values = poorer visual acuity, negative values = better visual acuity). Change over time measured at insertion, 12-hours, 1-week.
Investigator's Objective Assessment of Visual Acuity, High Contrast at Low Illumination (Snellen)Insertion, 12-hours, 1-weekInvestigators tested participants using snellen charts distant to the participant in each eye (monocular) at low lighting conditions (low illumination). (logMAR, 0.00 = 20/20 Snellen acuity, positive values = poorer visual acuity, negative values = better visual acuity). Change over time measured at insertion, 12-hours, 1-week.
Investigator's Objective Assessment of Anterior Ocular Physiological Response, Cornea (Biomicroscopy)Baseline, 12-hours, 1-weekInvestigators assigned an anterior ocular physiological response grade by biomicroscopy assessment with corneal staining (grading scale, 0-4, 0=none, 4=severe) Change over time measured at baseline (screening and dispensing visit), 12-hours, 1-week
Investigator's Objective Assessment of Anterior Ocular Physiological Response, Conjunctiva (Biomicroscopy)Baseline, 12-hours, 1-weekInvestigators assigned an anterior ocular physiological response grade by biomicroscopy assessment with conjuncitval staining (grading scale, 0-4, 0=none, 4=severe) Change over time measured at baseline (screening and dispensing visit), 12-hours, 1-week

Countries

Canada

Participant flow

Pre-assignment details

Two participants were determined to be ineligible at the screening visit due to their level of astigmatism

Participants by arm

ArmCount
All Participants
Each participant was randomized to wear the test lens in one eye and the control lens in the other simultaneously Etafilcon A Stenfilcon A
44
Total44

Baseline characteristics

CharacteristicAll Participants
Age, Categorical
<=18 years
1 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
43 Participants
Age, Continuous26.9 years
STANDARD_DEVIATION 9.5
Region of Enrollment
Canada
44 participants
Sex: Female, Male
Female
33 Participants
Sex: Female, Male
Male
11 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 44
serious
Total, serious adverse events
0 / 44

Outcome results

Primary

Participant's Subjective Rating of Comfort (Questionnaire)

Participants rated their comfort of lenses by subjective questionnaire (un-annotated scale, 0-100, 0=Poor comfort/intolerable, 100=Excellent comfort/cannot be felt) Change over time measured at insertion, After settling, 12-hours, 1-week

Time frame: Insertion, After Lens settling, 12-hours, 1-week

Population: One participant temporarily discontinued from study after 12-hour visit. (n=43 at 1-week visit)

ArmMeasureGroupValue (MEAN)Dispersion
Etafilcon AParticipant's Subjective Rating of Comfort (Questionnaire)Insertion92 units on a scaleStandard Deviation 11
Etafilcon AParticipant's Subjective Rating of Comfort (Questionnaire)After settling96 units on a scaleStandard Deviation 7
Etafilcon AParticipant's Subjective Rating of Comfort (Questionnaire)12-hours91 units on a scaleStandard Deviation 12
Etafilcon AParticipant's Subjective Rating of Comfort (Questionnaire)1-week90 units on a scaleStandard Deviation 10
Stenfilcon AParticipant's Subjective Rating of Comfort (Questionnaire)1-week90 units on a scaleStandard Deviation 10
Stenfilcon AParticipant's Subjective Rating of Comfort (Questionnaire)Insertion91 units on a scaleStandard Deviation 11
Stenfilcon AParticipant's Subjective Rating of Comfort (Questionnaire)12-hours88 units on a scaleStandard Deviation 13
Stenfilcon AParticipant's Subjective Rating of Comfort (Questionnaire)After settling93 units on a scaleStandard Deviation 10
Primary

Participant's Subjective Rating of Dryness (Questionnaire)

Participants rated dryness of the lenses by subjective questionnaire (annotated scale, 0-100, 0=cannot be worn / extremely dry, 100=no dryness experienced at any time) Change over time measured at 12-hours, 1-week

Time frame: 12-hours, 1-week

ArmMeasureGroupValue (MEAN)Dispersion
Etafilcon AParticipant's Subjective Rating of Dryness (Questionnaire)12-hours86 units on a scaleStandard Deviation 17
Etafilcon AParticipant's Subjective Rating of Dryness (Questionnaire)1-week83 units on a scaleStandard Deviation 20
Stenfilcon AParticipant's Subjective Rating of Dryness (Questionnaire)12-hours83 units on a scaleStandard Deviation 21
Stenfilcon AParticipant's Subjective Rating of Dryness (Questionnaire)1-week82 units on a scaleStandard Deviation 21
Primary

Participant's Subjective Rating of Lens Handling for Insertion (Questionnaire)

Participants rated their lens handling experience for lens insertion by questionnaire (un-annotated scale, 0-100, 0=could not place lens on eye, 100=always easy to place lens on eye) Measured at Dispensing

Time frame: Dispense

ArmMeasureValue (MEAN)Dispersion
Etafilcon AParticipant's Subjective Rating of Lens Handling for Insertion (Questionnaire)80 score on a scaleStandard Deviation 19
Stenfilcon AParticipant's Subjective Rating of Lens Handling for Insertion (Questionnaire)86 score on a scaleStandard Deviation 14
Primary

Participant's Subjective Rating of Lens Handling for Removal (Questionnaire)

Participants rated their lens handling experience for the lens removal by questionnaire (un-annotated scale, 0-100, 0=could not remove lens from eye, 100=always easy to remove lens from eye) Change over time measured at 12-hours, 1-week

Time frame: 12-hours, 1-week

Population: One participant temporarily discontinued from study after 12-hour visit. (n=43 at 1-week visit)

ArmMeasureGroupValue (MEAN)Dispersion
Etafilcon AParticipant's Subjective Rating of Lens Handling for Removal (Questionnaire)12-hours97 units on a scaleStandard Deviation 7
Etafilcon AParticipant's Subjective Rating of Lens Handling for Removal (Questionnaire)1-week94 units on a scaleStandard Deviation 12
Stenfilcon AParticipant's Subjective Rating of Lens Handling for Removal (Questionnaire)12-hours92 units on a scaleStandard Deviation 15
Stenfilcon AParticipant's Subjective Rating of Lens Handling for Removal (Questionnaire)1-week94 units on a scaleStandard Deviation 9
Primary

Participant's Subjective Rating of Overall Preference (Questionnaire)

Participants rated their overall lens preference by questionnaire. (annotated scale, 0-100, scale normalized to 0=no preference, +50=strongly prefers test lens, -50=strongly prefers control lens). Change over time measured at 12-hours, 1-week

Time frame: 12-hours, 1-week

ArmMeasureGroupValue (MEAN)Dispersion
Etafilcon AParticipant's Subjective Rating of Overall Preference (Questionnaire)12-hours-8 score on a scaleStandard Deviation 24
Etafilcon AParticipant's Subjective Rating of Overall Preference (Questionnaire)1-week5 score on a scaleStandard Deviation 16
Primary

Participant's Subjective Rating of Visual Quality (Questionnaire)

Participants rated visual quality of the lenses by questionnaire (annotated scale, 0-100, 0=extremely poor vision all of the time. Cannot function, 100=excellent vision all of the time) Change over time measured at 12-hours, 1-week

Time frame: 12-hours, 1-week

ArmMeasureGroupValue (MEAN)Dispersion
Etafilcon AParticipant's Subjective Rating of Visual Quality (Questionnaire)12-hours92 units on a scaleStandard Deviation 13
Etafilcon AParticipant's Subjective Rating of Visual Quality (Questionnaire)1-week89 units on a scaleStandard Deviation 12
Stenfilcon AParticipant's Subjective Rating of Visual Quality (Questionnaire)12-hours89 units on a scaleStandard Deviation 15
Stenfilcon AParticipant's Subjective Rating of Visual Quality (Questionnaire)1-week89 units on a scaleStandard Deviation 14
Secondary

Investigator's Objective Assessment of Anterior Ocular Physiological Response, Conjunctiva (Biomicroscopy)

Investigators assigned an anterior ocular physiological response grade by biomicroscopy assessment with conjuncitval staining (grading scale, 0-4, 0=none, 4=severe) Change over time measured at baseline (screening and dispensing visit), 12-hours, 1-week

Time frame: Baseline, 12-hours, 1-week

ArmMeasureGroupValue (MEAN)Dispersion
Etafilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Conjunctiva (Biomicroscopy)baseline Temporal0.15 units on a scaleStandard Deviation 0.25
Etafilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Conjunctiva (Biomicroscopy)12-hours Superior0.17 units on a scaleStandard Deviation 0.24
Etafilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Conjunctiva (Biomicroscopy)baseline Inferior0.09 units on a scaleStandard Deviation 0.29
Etafilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Conjunctiva (Biomicroscopy)12-hours Inferior0.63 units on a scaleStandard Deviation 0.74
Etafilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Conjunctiva (Biomicroscopy)baseline Nasal0.23 units on a scaleStandard Deviation 0.035
Etafilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Conjunctiva (Biomicroscopy)1-week Nasal0.83 units on a scaleStandard Deviation 0.62
Etafilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Conjunctiva (Biomicroscopy)12-hours Nasal0.86 units on a scaleStandard Deviation 0.73
Etafilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Conjunctiva (Biomicroscopy)1-week Temporal0.34 units on a scaleStandard Deviation 0.41
Etafilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Conjunctiva (Biomicroscopy)baseline Superior0.06 units on a scaleStandard Deviation 0.19
Etafilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Conjunctiva (Biomicroscopy)1-week Superior0.17 units on a scaleStandard Deviation 0.3
Etafilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Conjunctiva (Biomicroscopy)12-hours Temporal0.55 units on a scaleStandard Deviation 0.55
Etafilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Conjunctiva (Biomicroscopy)1-week Inferior0.65 units on a scaleStandard Deviation 0.85
Stenfilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Conjunctiva (Biomicroscopy)12-hours Temporal0.93 units on a scaleStandard Deviation 0.59
Stenfilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Conjunctiva (Biomicroscopy)baseline Nasal0.21 units on a scaleStandard Deviation 0.38
Stenfilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Conjunctiva (Biomicroscopy)baseline Temporal0.11 units on a scaleStandard Deviation 0.21
Stenfilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Conjunctiva (Biomicroscopy)baseline Superior0.06 units on a scaleStandard Deviation 0.19
Stenfilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Conjunctiva (Biomicroscopy)baseline Inferior0.08 units on a scaleStandard Deviation 0.26
Stenfilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Conjunctiva (Biomicroscopy)12-hours Nasal0.72 units on a scaleStandard Deviation 0.57
Stenfilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Conjunctiva (Biomicroscopy)1-week Inferior0.50 units on a scaleStandard Deviation 0.66
Stenfilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Conjunctiva (Biomicroscopy)12-hours Superior0.59 units on a scaleStandard Deviation 0.73
Stenfilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Conjunctiva (Biomicroscopy)12-hours Inferior0.76 units on a scaleStandard Deviation 0.68
Stenfilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Conjunctiva (Biomicroscopy)1-week Nasal0.52 units on a scaleStandard Deviation 0.56
Stenfilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Conjunctiva (Biomicroscopy)1-week Temporal0.55 units on a scaleStandard Deviation 0.57
Stenfilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Conjunctiva (Biomicroscopy)1-week Superior0.33 units on a scaleStandard Deviation 0.44
Secondary

Investigator's Objective Assessment of Anterior Ocular Physiological Response, Cornea (Biomicroscopy)

Investigators assigned an anterior ocular physiological response grade by biomicroscopy assessment with corneal staining (grading scale, 0-4, 0=none, 4=severe) Change over time measured at baseline (screening and dispensing visit), 12-hours, 1-week

Time frame: Baseline, 12-hours, 1-week

ArmMeasureGroupValue (MEAN)Dispersion
Etafilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Cornea (Biomicroscopy)baseline Inferior0.70 units on a scaleStandard Deviation 0.97
Etafilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Cornea (Biomicroscopy)12-hours Superior0.23 units on a scaleStandard Deviation 0.45
Etafilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Cornea (Biomicroscopy)baseline Nasal0.47 units on a scaleStandard Deviation 0.67
Etafilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Cornea (Biomicroscopy)12-hours Inferior0.68 units on a scaleStandard Deviation 0.89
Etafilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Cornea (Biomicroscopy)12-hours Central0.08 units on a scaleStandard Deviation 0.26
Etafilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Cornea (Biomicroscopy)1-week Central0.10 units on a scaleStandard Deviation 0.35
Etafilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Cornea (Biomicroscopy)baseline Superior0.30 units on a scaleStandard Deviation 0.6
Etafilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Cornea (Biomicroscopy)1-week Nasal0.23 units on a scaleStandard Deviation 0.51
Etafilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Cornea (Biomicroscopy)12-hours Nasal0.09 units on a scaleStandard Deviation 0.31
Etafilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Cornea (Biomicroscopy)1-week Temporal0.22 units on a scaleStandard Deviation 0.51
Etafilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Cornea (Biomicroscopy)baseline Temporal0.23 units on a scaleStandard Deviation 0.61
Etafilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Cornea (Biomicroscopy)1-week Superior0.17 units on a scaleStandard Deviation 0.44
Etafilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Cornea (Biomicroscopy)12-hours Temporal0.24 units on a scaleStandard Deviation 0.61
Etafilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Cornea (Biomicroscopy)1-week Inferior0.69 units on a scaleStandard Deviation 0.74
Etafilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Cornea (Biomicroscopy)baseline Central0.08 units on a scaleStandard Deviation 0.28
Stenfilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Cornea (Biomicroscopy)1-week Inferior0.51 units on a scaleStandard Deviation 0.82
Stenfilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Cornea (Biomicroscopy)baseline Central0.23 units on a scaleStandard Deviation 0.48
Stenfilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Cornea (Biomicroscopy)baseline Nasal0.56 units on a scaleStandard Deviation 0.74
Stenfilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Cornea (Biomicroscopy)baseline Temporal0.14 units on a scaleStandard Deviation 0.38
Stenfilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Cornea (Biomicroscopy)baseline Superior0.25 units on a scaleStandard Deviation 0.51
Stenfilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Cornea (Biomicroscopy)baseline Inferior0.55 units on a scaleStandard Deviation 0.7
Stenfilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Cornea (Biomicroscopy)12-hours Central0.16 units on a scaleStandard Deviation 0.44
Stenfilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Cornea (Biomicroscopy)12-hours Nasal0.32 units on a scaleStandard Deviation 0.66
Stenfilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Cornea (Biomicroscopy)12-hours Temporal0.16 units on a scaleStandard Deviation 0.4
Stenfilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Cornea (Biomicroscopy)12-hours Superior0.32 units on a scaleStandard Deviation 0.51
Stenfilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Cornea (Biomicroscopy)12-hours Inferior0.74 units on a scaleStandard Deviation 0.87
Stenfilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Cornea (Biomicroscopy)1-week Central0.12 units on a scaleStandard Deviation 0.39
Stenfilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Cornea (Biomicroscopy)1-week Nasal0.24 units on a scaleStandard Deviation 0.48
Stenfilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Cornea (Biomicroscopy)1-week Temporal0.16 units on a scaleStandard Deviation 0.41
Stenfilcon AInvestigator's Objective Assessment of Anterior Ocular Physiological Response, Cornea (Biomicroscopy)1-week Superior0.23 units on a scaleStandard Deviation 0.54
Secondary

Investigator's Objective Assessment of Lens Surface Wettability (Biomicroscopy)

Investigators assigned a lens surface wettability grade by biomicroscopy assessment (grading scale, 0 to 4, 0=excellent, 4=severely reduced). Change over time measured after lens settling (insertion), after 12-hours wear on the dispense day (12-hours), after a minimum on one hour of lens wear at 1 week (1-week).

Time frame: Insertion, 12 hours, 1 week

ArmMeasureGroupValue (MEAN)Dispersion
Etafilcon AInvestigator's Objective Assessment of Lens Surface Wettability (Biomicroscopy)Insertion0.69 units on a scaleStandard Deviation 0.82
Etafilcon AInvestigator's Objective Assessment of Lens Surface Wettability (Biomicroscopy)12-hours1.51 units on a scaleStandard Deviation 1.26
Etafilcon AInvestigator's Objective Assessment of Lens Surface Wettability (Biomicroscopy)1-week1.06 units on a scaleStandard Deviation 1
Stenfilcon AInvestigator's Objective Assessment of Lens Surface Wettability (Biomicroscopy)Insertion0.78 units on a scaleStandard Deviation 0.89
Stenfilcon AInvestigator's Objective Assessment of Lens Surface Wettability (Biomicroscopy)12-hours1.47 units on a scaleStandard Deviation 1.16
Stenfilcon AInvestigator's Objective Assessment of Lens Surface Wettability (Biomicroscopy)1-week1.15 units on a scaleStandard Deviation 0.98
Secondary

Investigator's Objective Assessment of Overall Fit Acceptance (Biomicroscopy)

Investigators assigned an overall fit acceptance grade by biomicroscopy assessment (grading scale, 0-4, 0=very poor, 4=very good). Change over time measured at insertion, 12-hours, 1-week

Time frame: Insertion, 12 hours, 1 week

ArmMeasureGroupValue (MEAN)Dispersion
Etafilcon AInvestigator's Objective Assessment of Overall Fit Acceptance (Biomicroscopy)Insertion3.37 units on a scaleStandard Deviation 0.47
Etafilcon AInvestigator's Objective Assessment of Overall Fit Acceptance (Biomicroscopy)12-hours3.26 units on a scaleStandard Deviation 0.47
Etafilcon AInvestigator's Objective Assessment of Overall Fit Acceptance (Biomicroscopy)1-week3.36 units on a scaleStandard Deviation 0.4
Stenfilcon AInvestigator's Objective Assessment of Overall Fit Acceptance (Biomicroscopy)Insertion3.44 units on a scaleStandard Deviation 0.42
Stenfilcon AInvestigator's Objective Assessment of Overall Fit Acceptance (Biomicroscopy)12-hours3.40 units on a scaleStandard Deviation 0.37
Stenfilcon AInvestigator's Objective Assessment of Overall Fit Acceptance (Biomicroscopy)1-week3.48 units on a scaleStandard Deviation 0.31
Secondary

Investigator's Objective Assessment of Visual Acuity, High Contrast at High Illumination (Snellen)

Investigators tested participants using snellen charts distant to the participant in each eye (monocular) at normal lighting conditions (high illumination). (logMAR, 0.00 = 20/20 Snellen acuity, positive values = poorer visual acuity, negative values = better visual acuity). Change over time measured at insertion, 12-hours, 1-week.

Time frame: Insertion

ArmMeasureGroupValue (LOG_MEAN)Dispersion
Etafilcon AInvestigator's Objective Assessment of Visual Acuity, High Contrast at High Illumination (Snellen)Insertion-0.09 logMARStandard Deviation 0.09
Etafilcon AInvestigator's Objective Assessment of Visual Acuity, High Contrast at High Illumination (Snellen)12-hours-0.09 logMARStandard Deviation 0.07
Etafilcon AInvestigator's Objective Assessment of Visual Acuity, High Contrast at High Illumination (Snellen)1-week-0.09 logMARStandard Deviation 0.06
Stenfilcon AInvestigator's Objective Assessment of Visual Acuity, High Contrast at High Illumination (Snellen)Insertion-0.08 logMARStandard Deviation 0.08
Stenfilcon AInvestigator's Objective Assessment of Visual Acuity, High Contrast at High Illumination (Snellen)12-hours-0.08 logMARStandard Deviation 0.07
Stenfilcon AInvestigator's Objective Assessment of Visual Acuity, High Contrast at High Illumination (Snellen)1-week-0.08 logMARStandard Deviation 0.07
Secondary

Investigator's Objective Assessment of Visual Acuity, High Contrast at Low Illumination (Snellen)

Investigators tested participants using snellen charts distant to the participant in each eye (monocular) at low lighting conditions (low illumination). (logMAR, 0.00 = 20/20 Snellen acuity, positive values = poorer visual acuity, negative values = better visual acuity). Change over time measured at insertion, 12-hours, 1-week.

Time frame: Insertion, 12-hours, 1-week

ArmMeasureGroupValue (LOG_MEAN)Dispersion
Etafilcon AInvestigator's Objective Assessment of Visual Acuity, High Contrast at Low Illumination (Snellen)Insertion-0.07 logMARStandard Deviation 0.08
Etafilcon AInvestigator's Objective Assessment of Visual Acuity, High Contrast at Low Illumination (Snellen)12-hours-0.07 logMARStandard Deviation 0.07
Etafilcon AInvestigator's Objective Assessment of Visual Acuity, High Contrast at Low Illumination (Snellen)1-week-0.08 logMARStandard Deviation 0.07
Stenfilcon AInvestigator's Objective Assessment of Visual Acuity, High Contrast at Low Illumination (Snellen)Insertion-0.06 logMARStandard Deviation 0.07
Stenfilcon AInvestigator's Objective Assessment of Visual Acuity, High Contrast at Low Illumination (Snellen)12-hours-0.07 logMARStandard Deviation 0.07
Stenfilcon AInvestigator's Objective Assessment of Visual Acuity, High Contrast at Low Illumination (Snellen)1-week-0.07 logMARStandard Deviation 0.07

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026